Also listed on Allergan Medical SARL, an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Oct 24, 2024 (Ascent Partners Fund LLC).
Term ends Apr 1, 2031 · High confidence
20-year base term ends Oct 6, 2029
Held by Reshape Lifesciences Inc.
Filed Oct 6, 2009 as application 12/574,640 · Granted Nov 27, 2012
Base term plus 542 days of patent term adjustment (USPTO delay)
Today
2009
2031
Clock starts
Oct 6, 2009
Oct 6, 2009
Term ends
Apr 1, 2031
Apr 1, 2031
Granted
Nov 27, 2012
Nov 27, 2012
base term
patent term adjustment
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
542
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 542 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 6, 2009, when this application, 12/574,640, was filed | Oct 6, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +542 days, USPTO patent term adjustment record | Apr 1, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 1, 2031 | High confidence |
This family
| US 8,317,677 | this patent Apr 2031 | Apr 2031 |
| Application 12/816,310 | Abandoned not computed | not computed |
| Application PCT/US2011/040257 | PCT application no patent term | no patent term |
| Application 14/143,510 | Abandoned not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 7, 2009 Reel 23612, frame 353 | Bertolote, Tiago; Fridez, Pierre | Allergan, Inc. | Assignment of Assignor's Interest |
| Dec 31, 2013 Reel 31861, frame 645 | Allergan Medical SARL | Apollo Endosurgery, Inc. | Assignment of Assignor's Interest |
| Jan 2, 2014 Reel 31910, frame 460 | Apollo Endosurgery, Inc. | Oxford Finance LLC, as Agent | Security Agreement |
| Jan 7, 2014 Reel 31925, frame 103 | Allergan Medical SARL | Apollo Endosurgery, Inc. | Corrective Assignment to Correct the Execution Date Previously Recorded on Reel 031861 Frame 0645. Assignor(S) Hereby Confirms the Assignment of Assignors Interest. |
| Mar 2, 2015 Reel 35120, frame 740 | Oxford Finance LLC, as Agent | Apollo Endosurgery, Inc. | Termination of Patent Security Interest (Recorded on 12/3/13 at Reel/Frame 031756/0729 and on 1/2/14 at Reel/Frame 031910/0460) |
| Mar 2, 2015 Reel 35120, frame 843 | Apollo Endosurgery, Inc. | Athyrium Opportunities II Acquisition LP, as Administrative Agent | Notice of Grant of Security Interest in Patents |
| May 5, 2015 Reel 35562, frame 610 | Allergan, Inc. | Allergan Medical SARL | Assignment of Assignor's Interest |
| Dec 30, 2016 Reel 41224, frame 821 | Apollo Endosurgery US, Inc. | Athyrium Opportunities II Acquisition LP, as Administrative Agent | Notice of Grant of Security Interest in Patents |
| Mar 27, 2017 Reel 42106, frame 912 | Apollo Endosurgery, Inc. | Apollo Endosurgery US, Inc. | Change of Name |
| Jan 4, 2019 Reel 48012, frame 902 | Athyrium Opportunities II Acquisition LP, as Administrative Agent | Apollo Endosurgery US, Inc. | Termination and Release of Security Interest in Patents |
| May 19, 2020 Reel 52701, frame 252 | Apollo Endosurgery US, Inc. | Reshape Lifesciences Inc. | Assignment of Assignor's Interest |
| Oct 24, 2024 Reel 70166, frame 882 | Reshape Lifesciences Inc. | Ascent Partners Fund LLC | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2031
Term ends Apr 1, 2031. No further fees fall due before then
Note
The 542 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
102
later US patents cite this one
That is top 10% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.